Clinical relevance and treatment of nonautoimmune anemia in chronic lymphocytic leukemia

References

• JemalASiegelRWardEHaoYXuJThunMJCancer statistics, 2009CA Cancer J Clin20095922524919474385
   PubMed Web of Science ®Google Scholar
• CatovskyDRichardsSMatutesEAssessment of fludarabine plus cyclophosphamide for patients with chronic lymphocytic leukaemia (the LRF CLL4 trial): A randomized controlled trialLancet200737023023917658394
   PubMed Web of Science ®Google Scholar
• HillmenPSkotnickiABRobakTAlemtuzumab compared with chlorambucil as first-line therapy for chronic lymphocytic leukemiaJ Clin Oncol2007255616562317984186
   PubMed Web of Science ®Google Scholar
• WierdaWGKippsTJMayerJOfatumumab as single agent CD20 immunotherapy in fludarabine-refractory chronic lymphocytic leukemiaJ Clin Oncol2010281749175520194866
   PubMed Web of Science ®Google Scholar
• KnaufWULissichkovTAldaoudAPhase III randomized study of bendamustine compared with chlorambucil in previously untreated patients with chronic lymphocytic leukemiaJ Clin Oncol2009274378438419652068
   PubMed Web of Science ®Google Scholar
• HillmenPCohenDRCocksKA randomized phase II trial of fludarabine, cyclophosphamide and mitoxantrone (FCM) with or without rituximab in previously treated chronic lymphocytic leukaemiaBr J Haematol201115257057821231927
   PubMed Web of Science ®Google Scholar
• GribbenJBHosingCMaloneyDGStem cell transplantation for indolent lymphoma and chronic lymphocytic leukemiaBiol Blood Marrow Transplant2011171 SupplS63S7021195313
   PubMed Web of Science ®Google Scholar
• PekovaSMazalOCmejlaRA comprehensive study of TP53 mutations in chronic lymphocytic leukemia: Analysis of 1287 diagnostic and 1148 follow-up CLL samplesLeuk Res1112011 [Epub ahead of print].
   Google Scholar
• FurmanRRPrognostic markers and stratification of chronic lymphocytic leukemiaHematology Am Soc Hematol Educ Program2010778121239774
   PubMed Web of Science ®Google Scholar
• MolicaSQuality of life in chronic lymphocytic leukemia: A neglected issueLeuk Lymphoma2005461709171416263572
   PubMed Web of Science ®Google Scholar
• ElseMSmithAGCocksKPatients’ experience of chronic lymphocytic leukaemia: Baseline health-related quality of life results from the LRF CLL4 trialBr J Haematol200814369069719016733
   PubMed Web of Science ®Google Scholar
• AbrisquetaPPereiraARozmanCImproving survival in patients with chronic lymphocytic leukemia (1980–2008): The Hospital Clinic of Barcelona experienceBlood20091142044205019553638
   PubMed Web of Science ®Google Scholar
• HallekMFischerKFingerle-RowsonGAddition of rituximab to fludarabine and cyclophosphamide in patients with chronic lymphocytic leukaemia: A randomised, open-label, phase 3 trialLancet20103761164117420888994
   PubMed Web of Science ®Google Scholar
• RobakTDmoszynskaASolal-CélignyPRituximab plus fludarabine and cyclophosphamide prolongs progression-free survival compared with fludarabine and cyclophosphamide alone in previously treated chronic lymphocytic leukemiaJ Clin Oncol2010281749175520194866
   PubMed Web of Science ®Google Scholar
• DeardenCDisease-specific complications of chronic lymphocytic leukemiaHematology Am Soc Hematol Educ Program200845045619074125
   PubMedGoogle Scholar
• TsopraOAZirosPGLagadinouEDDisease-related anemia in chronic lymphocytic leukemia is not due to intrinsic defects of erythroid precursors: A possible pathogenetic role for tumor necrosis factor-alphaActa Haematol200912118719519468203
   PubMed Web of Science ®Google Scholar
• SpivakJLGasconPLudwigHAnemia in management of oncology and hematologyOncologist200914Suppl 1435619762516
   PubMed Web of Science ®Google Scholar
• LetilovicTVrhovacRVerstovsekSJaksicBFerrajoliARole of angiogenesis in chronic lymphocytic leukemiaCancer200610792593416832815
   PubMed Web of Science ®Google Scholar
• MolicaSCutronaGVitelliGMarkers of increased angiogenesis and their correlation with biological parameters identifying high-risk patients in early B-cell chronic lymphocytic leukemiaLeuk Res2007311575157817485110
   PubMed Web of Science ®Google Scholar
• SchrjiversDHighleyMDeBruynERole of red blood cell in pharmacokinetics of chemotherapeutic agentsAnticancer Drugs19991014715310211544
   PubMed Web of Science ®Google Scholar
• BensonKBalducciLAaproMAnemia and cancerBalducciLErshlerWBBennettJMAnemia in the ElderlyNew York, NYSpringer2007
   Google Scholar
• RaiKRSawitskyACronkiteEPChananaADLevyRNPasternackBSClinical staging of chronic lymphocytic leukemiaBlood1975462192341139039
   PubMed Web of Science ®Google Scholar
• BinetJLAuquierADighieroGA new prognostic classification of chronic lymphocytic leukemia derived from a multivariate survival analysisCancer1981481982067237385
   PubMed Web of Science ®Google Scholar
• MorenoCHodgsonKFerrerGAutoimmune cytopenia in chronic lymphocytic leukemia: Prevalence, clinical associations and prognostic significanceBlood20101164771477620736453
   PubMed Web of Science ®Google Scholar
• RizzoJDBrouwersMHurleyPAmerican Society of Hematology/American Society of Clinical Oncology clinical practice guideline. Update on the use of epoetin and darbepoetin in adult patients with cancerJ Clin Oncol2010284996501020975064
   PubMed Web of Science ®Google Scholar
• RoseERaiKRevickiDBrownRReblandoJClinical and health status assessments in anemic chronic lymphocytic leukemia (CLL) patients treated with epoetin alfa (EPO)Blood199484Suppl Abstr 526a.
   Google Scholar
• SiakantarisMPAngelopoulouMKVassilakopoulosTPDimopoulouMNKontopidouFNPangalisGACorrection of disease-related anemia of B-chronic lymphoproliferative disorders by recombinant human erythropoietin: Maintenance is necessary to sustain responseLeuk Lymphoma20004014114711426615
   PubMed Web of Science ®Google Scholar
• ÖsterborgABrandbergYMolostovaVRandomized, double-blind, placebo-controlled trial of recombinant human erythropoietin, epoetin beta, in hematologic malignanciesJ Clin Oncol2002202486249412011126
   PubMed Web of Science ®Google Scholar
• PangalisGASiakantarisMPAngelopoulouMKDownstaging Rai stage III B-chronic lymphocytic leukemia patients with the administration of recombinant human erythropoietinHaematologica20028750050612010663
   PubMed Web of Science ®Google Scholar
• HenkeMLaszigRRubeCErythropoietin to treat head and neck cancer patients with anaemia undergoing radiotherapy: Randomized, double-blind, placebo controlled trialLancet20033621255126014575968
   PubMed Web of Science ®Google Scholar
• Leyland-JonesBSemiglazovVPawlickiMMaintaining normal hemoglobin levels with epoetin alfa in mainly nonanemic patients with metastatic breast cancer receiving first-line chemotherapy: A survival studyJ Clin Oncol2005235960597216087945
   PubMed Web of Science ®Google Scholar
• KokhaeiPAbdallaAOHanssonLExpression of erythropoietin receptor and in vitro functional effects of epoetins in B-cell malignanciesClin Cancer Res2007133536354417575216
   PubMed Web of Science ®Google Scholar
• AaproMOsterwalderBScherhagABurgerHUEpoetin-beta treatment in patients with cancer chemotherapy-induced anaemia: The impact of initial haemoglobin and target haemoglobin levels on survival, tumour progression and thromboembolic eventsBr J Cancer20091011961197119997109
   PubMed Web of Science ®Google Scholar
• LudwigHRaiKBladeJManagement of disease-related anemia in patients with multiple myeloma or chronic lymphocytic leukemia: Epoetin treatment recommendationsHemat J20023121130
   PubMedGoogle Scholar
• RizzoJDLichtinAEWoolfSHUse of epoetin in patients with cancer: Evidence-based clinical practice guidelines of the American Society of Clinical Oncology and the American Society of HematologyJ Clin Oncol2002204083410712351606
   PubMed Web of Science ®Google Scholar
• RizzoJDSomerfieldMRHagertyKLUse of epoetin and darbepoetin in patients with cancer: 2007 American Society of Clinical Oncology/American Society of Hematology clinical practice guideline updateJ Clin Oncol20082613214917954713
   PubMed Web of Science ®Google Scholar
• RossSDAllenIEHenryDHSeamanCSercusBGoodnoughLTClinical benefits and risks associated with epoetin and darbepoetin in patients with chemotherapy-induced anemia: A systematic review of the literatureClin Ther20062880183116860166
   PubMed Web of Science ®Google Scholar
• TimmerSADe BoerKKnaapenPGötteMJVan RossumACThe potential role of erythropoietin in chronic heart failure: From the correction of anemia to improved perfusion and reduced apoptosis?J Card Fail20091535336119398085
   PubMed Web of Science ®Google Scholar
• BrownJRImmunomodulators in chronic lymphocytic leukemia: Where does lenalidomide belong?Leuk Lymphoma2010511382138520624030
   PubMed Web of Science ®Google Scholar
• MauroFRGentileMFoaRErythropoietin and chronic lymphocytic leukemiaRev Clin Exp Hematol2002Suppl 1213112735212
   PubMedGoogle Scholar